ArticleTherapeutic advances in hematology2025

Safety of venetoclax in real-world experience: data from the French national database of pharmacovigilance through all indications in hematological malignancies over 5 years.

Alexis Talbot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.